Genmab — December 2017
-
Shorts er heller ikke nået op på 10% i Genmab endnu, som de var i Pandora

-
Nixen. I morgen kommer tech dealen
-
Der er i øvrigt få ting, der kan få en topledelse i spjældet. En af dem er, at lave aktiekøb, som beskrevet nedenfor
-
Spørg bare Don Ø....
-
De følger kursen nedad, men det er vel ikke så overraskende http://penge.borsen.dk/artikel/1/356364/jp_morgan_aendrer_kursmaal_for_tre_danske_aktier_saenker_genmab_15_pct.html?utm_source=forside&utm_campaign=nyhed_01
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind